203 related articles for article (PubMed ID: 26196185)
1. Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis.
Pan Y; Cao F; Guo A; Chang W; Chen X; Ma W; Gao X; Guo S; Fu C; Zhu J
Br J Cancer; 2015 Sep; 113(5):763-72. PubMed ID: 26196185
[TBL] [Abstract][Full Text] [Related]
2. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
[TBL] [Abstract][Full Text] [Related]
3. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
4. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
5. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
6. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
7. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
8. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
[TBL] [Abstract][Full Text] [Related]
9. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer.
Peng H; Pan X; Su Q; Zhu LS; Ma GD
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8332-8344. PubMed ID: 31646563
[TBL] [Abstract][Full Text] [Related]
10. BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.
Zhu GD; Liu F; OuYang S; Zhou R; Jiang FN; Zhang B; Liao WJ
Biochem Biophys Res Commun; 2018 May; 499(2):120-127. PubMed ID: 29481800
[TBL] [Abstract][Full Text] [Related]
11. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage Colorectal Cancer.
Li J; Yin M; Song W; Cui F; Wang W; Wang S; Zhu H
Cell Physiol Biochem; 2018; 45(1):237-249. PubMed ID: 29357321
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis.
Sun J; Liu X; Gao H; Zhang L; Ji Q; Wang Z; Zhou L; Wang Y; Sui H; Fan Z; Li Q
Oncotarget; 2017 Feb; 8(7):11489-11506. PubMed ID: 28009989
[TBL] [Abstract][Full Text] [Related]
13. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MSK1 is associated with tumor aggressiveness and poor prognosis in colorectal cancer.
Fu X; Fan X; Hu J; Zou H; Chen Z; Liu Q; Ni B; Tan X; Su Q; Wang J; Wang L; Wang J
Dig Liver Dis; 2017 Jun; 49(6):683-691. PubMed ID: 28314603
[TBL] [Abstract][Full Text] [Related]
15. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78.
Tsai HY; Yang YF; Wu AT; Yang CJ; Liu YP; Jan YH; Lee CH; Hsiao YW; Yeh CT; Shen CN; Lu PJ; Huang MS; Hsiao M
Oncogene; 2013 Oct; 32(41):4921-31. PubMed ID: 23318453
[TBL] [Abstract][Full Text] [Related]
17. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
18. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
[TBL] [Abstract][Full Text] [Related]
19. Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.
Liu G; Zhu J; Yu M; Cai C; Zhou Y; Yu M; Fu Z; Gong Y; Yang B; Li Y; Zhou Q; Lin Q; Ye H; Ye L; Zhao X; Li Z; Chen R; Han F; Tang C; Zeng B
J Transl Med; 2015 May; 13():144. PubMed ID: 25947346
[TBL] [Abstract][Full Text] [Related]
20. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]